Hospitals, Immunization and Research Laboratories

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Hospitals

Immunization

Research Laboratories

FDA Approves Clesrovimab-cfor for Prevention of RSV in Infants

Drug Topics

JUNE 10, 2025

RSV disease is the leading cause of infant hospitalization in the US and can lead to serious respiratory conditions like bronchiolitis and pneumonia,” Octavio Ramilo, an investigator on the CLEVER and SMART trials., said in a release.

FDA

FDA Vaccines Adverse Reactions Specialty Pharmacies

FDA approves MSD’s Keytruda to treat head and neck cancer

Pharmaceutical Technology

JUNE 16, 2025

Keytruda is designed to enhance the immune system’s ability to detect and combat tumour cells. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

FDA

FDA Research Laboratories Communication Hospitals

Pharmacy Technician Pulse

FDA Approves Clesrovimab-cfor for Prevention of RSV in Infants

FDA approves MSD’s Keytruda to treat head and neck cancer

Stay Connected